Adams Accelerates Mucinex D Launch, Plans Expanded TV Ad Campaign
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics expects its history of detailing pharmacists about the Mucinex brand to be beneficial if restrictions on pseudoephedrine-containing products require Mucinex D to be placed behind pharmacy counters
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning